Exelixis, Inc. (EXEL) Presents at Stifel 2026 Targeted Oncology Virtual Forum TranscriptSeeking Alpha • 05/20/26
EXEL Collaborates With MRK for Late-Stage Colorectal Cancer StudyZacks Investment Research • 05/20/26
Exelixis, Inc. (EXEL) Presents at RBC Capital Markets Global Healthcare Conference 2026 TranscriptSeeking Alpha • 05/19/26
Exelixis Announces Clinical Development Collaboration with Merck for Phase 3 STELLAR-316 Pivotal Trial for Patients with Colorectal CancerBusiness Wire • 05/19/26
Exelixis, Inc. (EXEL) Presents at Bank of America Global Healthcare Conference 2026 TranscriptSeeking Alpha • 05/12/26
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in MayBusiness Wire • 05/07/26
Exelixis (EXEL) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 05/05/26
Exelixis Announces First Quarter 2026 Financial Results and Provides Corporate UpdateBusiness Wire • 05/05/26
Exelixis to Release First Quarter 2026 Financial Results on Tuesday, May 5, 2026Business Wire • 04/21/26
Exelixis (EXEL) Down 2.8% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/12/26
Exelixis, Inc. (EXEL) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptSeeking Alpha • 03/11/26
Exelixis, Inc. (EXEL) Presents at The Citizens Life Sciences Conference 2026 TranscriptSeeking Alpha • 03/11/26
Exelixis, Inc. (EXEL) Presents at Leerink Global Healthcare Conference 2026 TranscriptSeeking Alpha • 03/10/26
Exelixis, Inc. (EXEL) Presents at TD Cowen 46th Annual Health Care Conference TranscriptSeeking Alpha • 03/04/26
3 Reasons Exelixis Stock Could Deliver Market‑Beating Returns Over the Next DecadeThe Motley Fool • 02/28/26